Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

[Prostate cancer: promising biomarkers related to aggressive disease].

Ribeiro da Silva MN, Tobias-Machado M, Lima-Pompeo AC, Reis LO, da Silva Pinhal MA.

Actas Urol Esp. 2012 Sep;36(8):484-90. Epub 2012 Apr 18. Review. Spanish.

PMID:
22520043
2.

The role of genetic markers in the management of prostate cancer.

Choudhury AD, Eeles R, Freedland SJ, Isaacs WB, Pomerantz MM, Schalken JA, Tammela TL, Visakorpi T.

Eur Urol. 2012 Oct;62(4):577-87. doi: 10.1016/j.eururo.2012.05.054. Epub 2012 Jun 5. Review.

PMID:
22695242
3.

Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.

Troyer DA, Mubiru J, Leach RJ, Naylor SL.

Dis Markers. 2004;20(2):117-28. Review.

4.

Predicting high-risk disease using tissue biomarkers.

Donovan MJ, Cordon-Cardo C.

Curr Opin Urol. 2013 May;23(3):245-51. doi: 10.1097/MOU.0b013e32835f89cc. Review.

PMID:
23478499
5.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Review.

PMID:
21871709
6.

"Just Another Statistic"

Machtay M, Glatstein E.

Oncologist. 1998;3(3):III-IV.

PMID:
10388105
7.

Prognostic markers in clinically localized prostate cancer.

Pettaway CA.

Tech Urol. 1998 Mar;4(1):35-42. Review.

PMID:
9568775
8.

Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.

Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Buffi N, Guazzoni G, Lazzeri M.

Korean J Urol. 2014 Jul;55(7):436-45. doi: 10.4111/kju.2014.55.7.436. Epub 2014 Jul 11. Review.

10.

[New biomarkers for the prostate cancer].

Ishii G, Kimura T, Kuruma H, Egawa S.

Nihon Rinsho. 2012 May;70(5):828-32. Review. Japanese.

PMID:
22620008
11.

MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.

Gordanpour A, Nam RK, Sugar L, Seth A.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):314-9. doi: 10.1038/pcan.2012.3. Epub 2012 Feb 14. Review.

PMID:
22333688
12.

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.

Fredolini C, Liotta LA, Petricoin EF.

Crit Rev Clin Lab Sci. 2010 May-Jun;47(3):125-38. doi: 10.3109/10408363.2010.503558. Epub 2010 Sep 21. Review.

PMID:
20858067
13.

Biomarkers for prostate cancer detection.

Reed AB, Parekh DJ.

Expert Rev Anticancer Ther. 2010 Jan;10(1):103-14. doi: 10.1586/era.09.168. Review.

PMID:
20014890
14.

Endpoints in prostate cancer clinical trials.

Sartor O.

Urology. 2002 Sep;60(3 Suppl 1):101-7; discussion 107-8. Review.

PMID:
12231062
15.

Prognostic value of serum markers for prostate cancer.

Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.

Scand J Urol Nephrol Suppl. 2005 May;(216):64-81. Review.

PMID:
16019759
16.

Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.

Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA.

J Urol. 2014 Jul;192(1):252-9. doi: 10.1016/j.juro.2014.01.107. Epub 2014 Feb 8.

PMID:
24518785
17.

A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.

Ashour N, Angulo JC, Andrés G, Alelú R, González-Corpas A, Toledo MV, Rodríguez-Barbero JM, López JI, Sánchez-Chapado M, Ropero S.

Prostate. 2014 Sep;74(12):1171-82. doi: 10.1002/pros.22833. Epub 2014 Jun 24.

PMID:
24961912
18.

[VALUE OF THE -2PROPSA INDEX AND THE PROSTATE HEALTH INDEX IN PATIENTS WITH PROSTATE CANCER: REVIEW OF LITERATURE AND DATA OF RUSSIAN PROSPECTIVE STUDY].

Kolontarev KB, Govorov AV, Osipova TA, Sidorenkov AV, Pushkar DY.

Urologiia. 2015 Jan-Feb;(1):49-53. Review. Russian.

PMID:
26094387
19.

Early detection of prostate cancer: European Association of Urology recommendation.

Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, Wirth M, Mottet N; European Association of Urology.

Eur Urol. 2013 Sep;64(3):347-54. doi: 10.1016/j.eururo.2013.06.051. Epub 2013 Jul 9. Review.

PMID:
23856038
20.

Molecular markers and death from prostate cancer.

Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK.

Ann Intern Med. 2009 May 5;150(9):595-603.

PMID:
19414838

Supplemental Content

Support Center